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Abstract: 
Manganese (Mn) is an essential metal that can exert toxic effects at high concentrations, eventually leading to 
Parkinsonism. A major transporter of Mn in mammals is the divalent-metal transporter (DMT1). We 
characterize here DMT1-like proteins in the nematode C. elegans, which regulate and are regulated by Mn and 
iron (Fe) content. We identified three new DMT1-like genes in C. elegans: smf-1, smf-2 and smf-3. All three 
can functionally substitute for loss of their yeast orthologues in S. cerevisiae. In the worm, deletion of smf-1 or 
smf-3 led to an increased Mn tolerance, while loss of smf-2 led to increased Mn sensitivity. smf mRNA levels 
measured by QRT-PCR were up-regulated upon low Mn and down-regulated upon high Mn exposures. 
Translational GFPfusions revealed that SMF-1 and SMF-3 strongly localize to partially overlapping apical 
regions of the gut epithelium, suggesting a differential role for SMF-1 and SMF-3 in Mn nutritional intake. 
Conversely, SMF-2 was detected in the marginal pharyngeal epithelium, possibly involved in metal-sensing. 
Analysis of metal content upon Mn exposure in smf mutants revealed that SMF3 is required for normal Mn 
uptake, while smf-1 was dispensable. Higher smf-2 mRNA levels correlated with higher Fe content, supporting 
a role for SMF-2 in Fe uptake. In smf-1 and smf-3 but not in smf-2 mutants, increased Mn exposure led to 
decreased Fe levels, suggesting that both metals compete for transport by SMF-2. Finally, SMF-3 was post-
translationally and reversibly down-regulated following Mn-exposure. In sum, we unraveled a complex 
interplay of transcriptional and post-translational regulations of 3 DMT1-like transporters in two adjacent 
tissues, which regulate metal-content in C. elegans. 
 
Article: 
Introduction 
Manganese (Mn) is one of the most abundant natural elements in the Earth’s crust. It most frequently occurs in 
the form of oxides, carbonates and silicates [1]. It is one of 7 essential metals for animals, acting as a cofactor 
for multiple proteins with a wide variety of biological activities, such as transferases, hydrolases, lyases, 
arginase, glutamine synthetase, superoxide dismutase and integrins [2,3]. Consequently, Mn is essential for 
many physiological processes, such as modulation of the immune system, stellate process production in 
astrocytes, as well as protein, lipid and carbohydrate metabolism [4,5,6,7,8]. Mn is also essential for optimal 
brain and skeletal structure development [9,10]; Mn deficiency has been associated with defective bone 
formation and increased susceptibility to seizures [11,12]. Despite being essential for metabolic functions, Mn 
at high concentrations can be toxic, especially to the brain. Though most Mn is obtained through the diet, Mn 
toxicity from dietary intake is rare, because Mn balance is tightly regulated by both the enterocytes (intake) and 
the biliary duct cells (excretion). In contrast, pulmonary uptake and particulate transport via the olfactory bulb 
[2,13,14] can lead to deposition of Mn within the striatum and cerebellum, and inflammation of the nasal 
epithelium [15]. Exposure to excessive Mn levels may cause an extrapyramidal syndrome, referred to as 
manganism, closely resembling idiopathic Parkinson’s disease (IPD), both at the molecular and clinical level 
[16,17,18]. Mn exposure represents a significant public health matter due to the use of Mn as a catalyser in 
countless industrial processes, its presence in gasoline additive, fungicides such as Maneb and in permanganate, 
a drinking water purifier [1,2,19,20,21]. Because Mn is the only environmental toxicant that has been robustly 
associated with IPD, studies on the mechanisms that mediate its toxicity offer means for better understanding of 
neurodegenerative diseases, the frequency of which is on the rise [22,23,24]. 
 
Due to the delicate relationship between essentiality and toxicity, Mn homeostasis is crucial for all eukaryotes. 
Previous research has focused on Mn transport mechanisms across the blood-brain barrier (BBB), but the nature 
and relative contributions of the carrier(s) identified thus far remain controversial. Over the past two decades, 
active transport [25] and facilitated diffusion [26,27] mechanisms have been described. More recently, Mn 
transport has been ascribed to high affinity metal transporters of calcium (Ca) and iron (Fe). Amongst these, 
attention has been directed to the divalent metal transporter (DMT1 [28]), which belongs to the family of 
natural resistance-associated macrophage protein (NRAMP) [29,30,31,32]. To avoid confusion, we will further 
refer to NRAMP family members as DMT(s) for Divalent Metal Transporter(s). 
 
DMT1, previously known as NRAMP2, was first identified as an orthologue of NRAMP1, a protein involved in 
host defense against several types of infection [29,30]. Subsequently, it was referred to as divalent cation 
transporter (DCT1), because of its ability to transport divalent zinc (Zn
2+
), manganese (Mn
2+
), cobalt (Co
2+
), 
cadmium (Cd
2+
), copper (Cu
2+
), nickel (Ni
2+
), lead (Pb 
2+
), and iron (Fe
2+
) [32,33,34]. In 1999 it was designated 
as DMT1 [28]. DMT1 is an integral membrane protein conserved from bacteria to humans, containing 11 to 12 
transmembrane domains (TMD) and a ―consensus transport sequence‖ (CTS) involved in divalent metal ion 
transport [32,33,34,35]. Notably, rodent models presenting a spontaneous mutation in DMT1, microcytic (mk) 
mice and Belgrade (b/b) rats [36], and several human mutations in DMT1 [37,38,39,40,41,42] suggest an 
association between microcytic anemia, impairment of Fe transport and Mn homeostasis. In vertebrates, DMT1 
is ubiquitously expressed, but more abundant expression is observed in the proximal duodenum compared to the 
kidney or the brain [28,32,43]. Within the brain, the basal ganglia express higher levels of DMT1, where Mn 
preferentially accumulates [44]. At a subcellular level, DMT1 is strongly localized at the apical membrane in 
enterocytes [45] and sustentacular cells of the olfactory epithelium [14] whereas in macrophages, it is restricted 
to the phagosomal membrane. The vertebrate DMT1 gene produces four alternatively spliced mRNAs differing 
by the presence or absence of the exon 0, and a 3' sequence in which an iron regulatory element is present or 
absent (+IRE and -IRE respectively). The 3' UTR is responsible for the modulation of the +IRE mRNA stability 
by the intracellular Fe pool [32]. The +IRE vs -IRE mRNAs encode DMT1 isoforms with distinct carboxy- 
termini [43,46]. The +IRE isoforms are found mainly at the apical membrane of epithelial cells [45,47] and in 
late endosomes and lysosomes within HEp-2 cells [40,48]. The -IRE isoforms are found predominantly in early 
and recycling endosomes [49,50,51]. Studies in yeast have identified three DMT1 orthologues: Smf1p, Smf2p 
and Smf3p, encoded by SMF1, SMF2 and SMF3 respectively. In contrast to vertebrate DMT1, no typical IRE is 
found in any of the SMF genes, and the poor sequence conservation of the C-termini is not predictive of a 
correspondence between the vertebrate IRE/ +IRE isoforms and Smf1p/2p/3p. However, Smf1p was identified 
as a non-specific metal ion transporter for Mn 
2+
, Zn
2+
, Cu
2+
, Fe
2+
 and Cd
2+
 [52,53] and Smf2p was also found 
to be involved in Mn transport [54]. Analogous to their vertebrate orthologues, the yeast DMTs are found in 
various intracellular compartments: Smf1p at the cell surface, Smf2p in vesicles and Smf3p exclusively at the 
vacuolar membrane [53,55,56]. In addition, they differentially contribute to Mn homeostasis, since Smfp 1 and 
Smf3p are dispensable in Mn-replete conditions [53], while Smf2p is essential for ensuring proper Mn uptake 
[57,58]. Additionally, the SMF3 promoter is found to contain a target sequence for the Fe-sensing transcription 
factor Aft1p, which is responsible for its transcriptional regulation by Fe, whereas Smf1p and Smf2p levels are 
unaffected by Fe concentration [55,56]. 
 
Currently, both Mn transport and DMT protein function(s) are poorly understood. This is partly due to the 
existence of several DMT proteins differentially regulated at the transcriptional and post-translational levels, in 
distinct tissues (intestine, liver, kidney, brain) and under various conditions (Mn or Fe levels, infection).  
Moreover, findings in a unicellular organism like the baker’s yeast are difficult to translate to metazoans and 
especially to mammals. Given the current lack of a genetically amenable animal model, we used the C. elegans 
system to address these issues. We identified and cloned three functional C. elegans DMT1 orthologues SMF-1, 
SMF-2 and SMF-3, with distinct roles in Mn transport regulation. Our results support an evolutionary 
conserved function for DMT1 isoforms in the regulation of Mn uptake, and emphasize the differential 
contribution and regulation of DMT1 isoforms expressed in different tissues and exhibiting different subcellular 
localizations. Furthermore, our study identifies SMF-3 as the main Mn uptake transporter in the worm, whereas 
SMF-1 has a minor role in this process and SMF-2 is involved in metal content regulation. 
 
Methods 
Multiple alignment generation and analysis. - Protein sequences were uploaded from the NCBI website 
(http://www.ncbi.nlm.nih.gov/ sites/entrez). Multiple alignments and phylogenetic trees were generated using 
ClustalX1.81 [59] running ClustalW [60]. 
 
Yeast handling, transformation and EGTA sensitivity assessment. - Yeast strains, maintenance, transformation 
and culture for the EGTA sensitivity assay were performed as described [58]. Plasmids pVTCesmf-1, pVT-
Cesmf-2 and pVT-Cesmf-3, for yeast expression of C. elegans genes smf-1, smf-2 and smf-3 respectively, were 
generated as follows. smf-1 (from yk452d4) and smf-3 (from yk397h3) cDNA were kindly provided by Yuji 
Kohara, while smf-2 cDNA was obtained by reverse-transcription-PCR. smf-1 was amplified using primers 5'- 
CAG CGG ATC CGC TTG ATA TCC TGC ATT GTC-3' and 5'-GAC CGG TAC CGG AAA GTA TAC ATC 
GTT CAC-3'. smf-3 was amplified using primers 5'-CGCGGATCCAATGGAGGTGAAATGAAAT-3' and 5'-
GCCCGGTACCGCATATCGCATAGACAGTTC-3'. smf-1’ smf-2, and smf-3 fragments were then cloned into 
pVT101-U using HindIII and PstI. 
 
C. elegans strains and handling of the worms. - C. elegans strains were handled and maintained at 20
°
C as 
previously described [61]. The following strains were used: N2 (wildtype); IG6, smf-1(eh5) X; VC171, smf-
2(gk133) X; RB1074, smf-3(ok1035) IV; MT455, lon2(e678) unc-18(e81) X; MT628, dpy-9(e12) unc-17(e245) 
IV. All strains were provided by the Caenorhabditis Genetic Center (CGC, Minnesota). The IG6, VC 171 and 
RB 1074 strains were outcrossed 4 additional times to generate MAB23, MAB21 and MAB37, respectively. 
 
Gene cloning and plasmid constructions. -- Restriction enzymes were ordered from New England Biolabs. 
PCR amplifications used the LA Taq
TM
 Polymerase (Takara), and were performed on an Eppendorf2 PCR-
machine. Translational C-terminal GFP-fusions for SMF-1, SMF-2 and SMF-3 localization were generated as 
follow. The smf-1 ORF and preceding intergenic region (4.4 kb) was amplified using primers: 5'- TAT TAC 
CTG CAG GAG CTA GCT TCA TGT TCA CCG CCA AGC TCG-3', and 5'- TAT TAG GAT CCA ATT 
GAT ATC CTG CAT TGT CAT GGA CTGC-3'. This fragment was cloned into the pPD95.75 vector (Fire kit) 
between the SbfI and BamHI restriction sites, in frame with the GFP (plasmid pMA0015). The smf-2 ORF with 
its preceding intergenic sequence (3.5 kb) was amplified using primers: 5'-TAT TCT GCA GTC ATA CGA 
AAA CGA TGC TCC GTG-3' and 5'-TAT TGG TAC CAC AAA GTA TAC ATC GTT CAC AAC-3'. The 
smf-3 ORF and its preceding intergenic region (8.4 kb) were amplified using primers: 5'-TAT TCT GCA GAC 
TTC ATT GGG GAT GTG CTT TGG-3' and 5'-GGT ACC CAA TAT CGC ATA GAC AGT TCG TCG-3'. 
The smf-2 and smf-3 amplification products were then cloned into pPD95.75 between the PstI and KpnI 
restriction sites, in frame with the GFP (plasmid pMA0010 and pMA0004 respectively). Transcriptional 
constructs for smf-1, smf-2 and smf-3 were obtained by cloning the preceding intergenic region, respectively up 
to the 2nd, 6
th
 and 7
th
 exon to include highly conserved intronic sequences. The following primer sets were 
used: 5'-CGC AAG CTT CGA GCA GCT CCG ATT G-3' and 5'-CGC CTG CAG CCT TGT GCG CCA GAC 
TGA AGG-3' for smf-1, 5'-TAT TGC ATG CTC ATA CGA AAA CGA TGC TCC GTG-3' and 5'-TAT TCT 
GCA GTA GTC CAA ACT GAC ATC CCA GG-3' for smf-2, 5'-TAT TCT GCA GAC TTC ATT GGG GAT 
GTG CTT TGG-3' and 5'-TAT TGT CGA CGG CTC TGG AAT ATA ATT AGG ATT GC-3' for smf-3. The 
smf-1 product (1.7 kb) was cloned between the HindIII and PstI restriction sites in pPD95.75 (promSmf1GFP1). 
The smf-2 (2.6 kb) fragment was cloned into pPD95.69 (Fire kit) between the SphI and PstI restriction sites 
(pMA0009). The smf-3 (5.5 kb) fragment was cloned into pPD95.69 between the restriction sites PstI and SalI 
(pMA0003). 
 
C. elegans transgenesis. - DNA was injected into the syncytial gonads of N2 hermaphrodites using injection 
mixes containing 25 ng/ml construct and 175 ng/ml pRF4 as a transformation marker [62]. A minimum of three 
independent transgenic strains per construct showing the same expression pattern were observed. One strain for 
each construct was selected for this study: MAB111, mjaEx074[SMF-1::GFP; rol-6(su1006)]; MAB120, 
mjaEx083[SMF2::GFP; rol-6(su1006)]; MAB105, mjaEx068[SMF-3::GFP; rol6(su1006)]. 
 
Acute manganese chloride treatments. - Manganese chloride (MnCl2) solutions were prepared in 85 mM 
NaCl. For each tested strain, 5000 synchronized L1 worms per tube were exposed to 0 to 4 M of MnCl2 in 
siliconized tubes for 30 minutes. Each condition was performed in tetraplicates. Worms were then pelleted by 
centrifugation at 7000 rpm for 3 minutes and washed 5 times in 85 mM NaCl. Worms from each of the 
siliconized tubes were then transferred into individual 100 mm OP50-1 coated NGM plates, which were then 
blinded. At 24 h post-treatment, for each plate, live worms were scored in 4 random 1 cm
2
 grids to estimate the 
total number of surviving worms (up to 800 counts per plate). Scores were normalized to percent control (0 mM 
MnCl2 exposure). 
 
Mn and Fe content measurement by atomic absorption spectrophotometry (AAS). - Triplicates of 7000 L1 
worms per condition were treated with MnCl2 as previously described. The samples were washed 8 times in 85 
mM NaCl. The samples were dehydrated in a vacuum oven at 65
°
C for 2 hours, and further digested in 200 ml 
ultrapure nitric acid for 24 hours in a sand-bath (60
°
C). A 20 ml aliquot of the digested sample was brought to 1 
ml total volume with 2% nitric acid and analyzed for Mn and Fe content using graphite furnace atomic 
absorption spectroscopy (AAS) (Varian AA240, Varian, Inc USA). Bovine liver digested in ultrapure nitric acid 
was used as an internal standard for analysis (NBS Standard Reference Material, USDC, Washington, DC, 
diluted at 5 mg Mn/L and 92 mg Fe/L). 
 
Epifluorescence, DIC and confocal microscopy. - For each slide, at least 30 worms were mounted on 4% 
agarose pads in M9, and anaesthetized with 0.2% tricaine/0.02% tetramisole in M9. Fluorescence observations 
and DIC imaging were performed with an epifluorescence microscope (Nikon Eclipse 80i, Nikon) equipped 
with a Lambda LS Xenon lamp (Sutter Instrument Company) and Nikon Plan Fluor 20x dry and Nikon Plan 
Apo 60x 1.3 oil objectives. The microscope was coupled to a black-and-white camera (DS-Qi1Mc; Nikon) 
operated by the Nikon Elements AR3.0 software (NES AR3.0) for image acquisitions. Confocal images 
acquired for illustration or GFP intensity measurement purposes were captured through Plan-Neofluar 40x, 
Plan-Apochromat 63x, or Plan-Neofluar 1006 oil objectives with a 1.3, 1.4 and 1.3 apertures, respectively, on a 
LSM510 confocal microscope (Carl Zeiss MicroImaging, Inc.), scanning every 200 nm for XZ sections. Images 
were processed with the Zeiss LSM Image Browser 4.0.0.157 software and edited using Photoshop 7.0 (Adobe). 
Microscopes were in air-conditioned rooms (20–22°C). 
 
Phenotypic characterization of Mn treated worms. - Following Mn treatment up to 24 h post-treatment, worms 
were observed under stereomicroscope (Zeiss), and mounted for microscopy phenotypic analysis using our 
Nikon platform aforementioned. After 24 h at 20
°
C, at least 30 random control worms and 30 treated worms 
exposed to 35 mM MnCl2, were imaged at 20x. We assessed their developmental stage (L1 or L2) and their 
size using NES AR3.0. 
 
SMF-3::GFP fluorescence measurements. - SMF-3::GFP transgenic worms (MAB 105) were acutely treated 
as described previously, transferred on OP50-1 seeded NGM plates and imaged at 1 h, 5 h and 30 h post-
treatment. Fluorescence measurements of SMF3::GFP signal were performed on complete confocal Z-stack 
projections of C. elegans gut. 5 to 12 animals of the same age were imaged for each condition. Treated and 
untreated animals were mounted on the same slide, and imaged with the same magnification, gain, offset, 
pinhole and laser power settings. Due to the very small signal/noise ratio for treated animals at 5 h, those 
settings allowed up to 30% signal saturation for some of the 5 h, 30 h control worms and 30 h recovering 
worms, so that fluorescence measurements for these conditions are underestimates. Mean signal intensity of the 
maximal projection of the apical membrane of the intestine (from the pharyngeal-intestinal valve to the rectum) 
was measured using the freeware ImageJ. 
 
Statistics. - Dose-response lethality curves and histograms for Mn content measurements were generated using 
GraphPad Prism (GraphPad Software Inc.). We used a sigmoidal dose-response model with a top constraint at 
100% to draw the curves and determine the LD50 values. Statistical analysis of significance was carried out by 
one-way ANOVA for the dose-response curves, and two-way ANOVA for Mn content measurements followed 
by post-hoc Bonferroni test when the overall p value was less than 0.05. For Fe content, Fisher test revealing 
differences in variances between the groups, two-tailed unpaired T-test with Welch’s correction were used to 
assess differences in Fe content. In all figures, error bars represent SEM, * p<0.05, ** p<0.01, *** p<0.001. 
 
RNA isolation, cDNA preparation and Real-time PCR. - 10000 N2, MAB21, MAB23 and MAB37 
synchronized L1 worms per tube were acutely treated with MnCl2 concentrations of 0, 0.1, 10 and 100 mM, 
washed in NaCl 85 mM, pelleted and frozen in liquid nitrogen. They were thawed on ice, frozen again in N2liq 
and resuspended in 100 mL H2O and 350 mL Trizol (Invitrogen Life Technologies) for RNA isolation. RNA 
extracts were purified using Qiagene RNeasy mini-kit (Qiagen). Messenger RNAs were reverse-transcribed 
with oligo-dT primers using the Superscript III RNAse H Reverse transcription kit (Invitrogen). cDNAs were 
stored at —20
°
C. Quantitative Real-time-PCR was carried on a ABISystems HT7900, using Brilliant SYBR 
Green I kit (Stratagene/Agilent Technologies Inc.), and HPLC purified primers (Operon) at a final concentration 
of 120 nM. For amplification of smf-1 cDNA, two sets of 22b primers were designed over the last intron 5'-
GCT CCG ATC ACC TTT GCA TAC G-3'/5'-ATC CTC GGA TGG AAA CGG TGT C-3', and between exons 
6 and 8 5'-TTT CGC ACA TGG ACT TTA CCA G-3'/5'- GCA ATA GCT CCA AAC TGG CAT C-3'. For 
smf-2, primers over intron 6 5'-TAT TCG CAG CAG GAC AAT CAT C-3'/5'-TTG TGC ATA ATC CGC TTA 
CTG G-3', and over intron 10 5'-GTT GCT TGC GAA CTT ATG AAC G-3'/5'- ACA AAG GTT TCT GTG 
ATC CAC G-3', were used. Smf-3 cDNA was amplified using primer sets 5'-TCC AGT GCT GAC ATT TGT 
ATC G-3'/5'-CAA GGA AAT CAC AAT GGA GAC C-3' over intron 10 and 5'-GGT CTC CAT TGT GATT 
TCC TTG-3'/5'-CGA AAT CGT GGT AGA TGG GCT CC-3' over intron 11. cdc-42 (primers: 5'-CTG CTG 
GAC AGG AAG ATT ACG-3'/5'-CTC GGA CAT TCT CGA ATG AAG-3') and Y45F10D4F.3 (primers: 5'-
GTC GCT TCA AAT CAG TTC AGC3'/5'-GTT CTT GTC AAG TGA TCC GAC A-3'), were used as controls 
to normalize smf expression levels as they were proven to have stable expression levels independent of age or 
stress conditions [63]. The amplification setup included 10' denaturation at 95°C, 20 cycles at 95°C for 
30"/58°C for 1'/70°C for 1', 20 to 25 cycles at 95°C for 30"/56°C for 45"/72°C for 45", and a dissociation curve 
to ascertain that the signal did not result from primer annealing. 
 
Results 
The C. elegans genome encodes 3 DMT1 orthologues: SMF-1, SMF-2, and SMF-3. A search on the C. elegans 
genome using the human DMT1 protein sequence revealed three loci encoding DMT1 orthologues: 
Y69A2AR.4/smf-3 on chromosome IV, and h'11 G12.3/smf-2 and h'11 G12.4/smf-1 on X chromosome. All 
three genes encode proteins with a high degree of conservation (Figure 1). Phylogenetic analysis placed them 
closer to their insects and vertebrates orthologues than plant and yeast divalent-metal transporters (Fig. 1A). A 
multiple alignment of the C. elegans SMF1, SMF-2, SMF-3 with their insect, vertebrates and yeast orthologues 
confirmed this analysis. All three C. elegans SMF exhibit a consensus transport sequence (CTS) quasi-identical 
to their vertebrate orthologues and 12 transmembrane domains (TMD), unlike the yeast SMF, in which the 11
th
 
TMD is absent and the CTS is conserved at 70% (Fig. 1B). 
 
SMF-1, SMF-2 and SMF-3 rescue the sensitivity to EGTA of the yeast ASMF1+2 mutant. In the yeast S. 
cerevisiae, Smf1p and Smf2p are divalent-metal transporters that can function in Mn uptake. Double mutants 
for ASMF1+2 are hypersensitive to the divalent-metal ion scavenger ethylene glycol tetra-acetic acid (EGTA). 
To assay the molecular function of C. elegans SMF-1, -2 and -3 proteins as divalent-metal transporters, we 
transvected the cDNA encoding each of the C. elegans proteins into the ASMF1+2 yeast mutant, and tested 
these transgenic strains for hypersensitivity to EGTA. All three C. elegans SMF were able to rescue the 
hypersensitivity to EGTA of the ASMF1+2 mutants (Fig. 2). Moreover, the efficacy of the rescue was at least 
equivalent to the rescue conferred by transvection of the mouse NRAMP2 cDNA construct [58]. Noticeably, the 
most potent effect was obtained with smf-1 cDNA, which led to a hyper-resistant phenotype to EGTA. These 
results indicate that C. elegans SMF-1, SMF-2 and SMF-3 are functionally similar to their yeast and mammal 
orthologues and are likely involved in divalent-metal ion transport. 
Mn exposure can induce lethal osmoregulation defects and a developmental delay in wild type worms. Acute 
exposure (30 minutes) of wild-type C. elegans to Mn was lethal at concentrations greater than 10 mM. 
 
Shortly after treatment and dependent upon the exposure level, a fraction of the worms displayed vacuoles in 
the main epithelia: epidermis, excretory cell and gut, tissues whose integrity is essential for worm survival (Fig. 
3). Loss of the excretory cell was the likely cause of death, since dying worms exhibited the characteristic rod-
like phenotype (Fig. 3F&G) inherent to excretory-cell defective mutants [64] and excretory-cell ablated worms 
[65]. Surviving worms at 24 h were about 70% shorter (Fig. 3H) and displayed an obvious developmental delay 
when compared with control animals. Twenty-four hours post-treatment 83% of survivors exposed to a 35 mM 
30 min Mn treatment were still at the L1 stage, compared to 13% in the control group (Fig. 3I). The lethal 
concentration 50% (LD50 at which half the worms are dead 24 hours after treatment) was 47 mM for the wild-
type Bristol N2 strain (Fig. 4). 
 
The deletion-mutants smf-1(eh5) and smf-3(ok1035) are hyper-resistant to Mn exposure. In rodents, Mn taken 
up by ingestion or inhalation is transported across the epithelial membrane via DMT1 [66]. If DMT1 
orthologues are responsible for Mn uptake in C. elegans, the loss of function or down-regulation of these 
transporters should reduce Mn sensitivity. To determine if smf-1, smf-2 and smf-3 are involved in Mn uptake 
and toxicity in the worm, we made use of available deletion-mutants for each of the three genes. Mutant smf-
1(eh5), smf-2(gk133) and smf-3(ok1035) strains were obtained from the Caenorhabditis Genetic Center (CGC). 
Under standard culture conditions, none of them displayed any obvious abnormal phenotype with respect to 
body morphology, development, growth, reproduction or behavior (data not shown). The smf-1 deletion eh5 
resulted in a truncated SMF-1 protein containing only the 6 first transmembrane domains and predicted to be 
devoid of Mn transport activity (Fig. 1B). When exposed to Mn, smf-1(eh5) mutants were twice as resistant as 
wild-type, with a LD50 = 94 mM (Fig. 4). The smf-3 deletion ok1035 removes about 1,8kb in a region 
encompassing exons 4 to 8. It leads to a loss of at least two of the transmembrane domains 1 to 8, preventing the 
resulting truncated protein from adopting its functional topology. In addition, the likely loss of TMD6 impairs 
divalent metal (Me
2+
) transport as this domain was proven essential for H
+
/Me
2+
 symporter activity [47] . In 
support of this assumption, the smf-3(ok1035) mutant displayed the highest resistance to Mn exposure with a 
LD50 = 126 mM (Fig. 4). The hyper-resistance to Mn exposure exhibited by both smf-1 (eh5) and smf-
3(ok1035) mutants suggests that the Mn-induced toxicity observed in wild type worms was at least, in part, 
mediated through Mn uptake by the DMT1-like isoforms. A reasonable explanation for this observation is that 
Mn uptake in these mutants is impaired and that both SMF-3 and SMF-1 are required for normal and optimal 
Mn uptake. 
 
The deletion mutant smf-2(gk133) is hypersensitive to Mn treatment. Concerning smf-2, the gk133 deletion 
affects the last hundred bases of its promoter up to the third intron, which likely results in the production of a 
defective protein, lacking the N-terminal sequence up to the 5
th
 TMD (Fig. 1B). Unlike smf-1(eh5) and smf-
3(ok1035), smf-2(gk133) mutant display a significant hypersensitivity to Mn exposure with a LD50 = 26 mM 
(Fig. 4), suggesting a protective role for SMF-2 against Mn toxicity. 
 
smf-3(ok1035) mutants take up less Mn while smf-2(gk133) mutants take up more. To confirm that the SMF 
proteins are involved in Mn uptake, following acute Mn exposure, we collected wild-type, smf1 (eh5), smf-
2(gk133), and smf-3(ok1035) worms, and processed them for Atomic Absorption Spectroscopy (AAS) analysis 
to measure their Mn content. All four strains showed dose-dependent increases in Mn content (Fig. 5A). smf-
1(eh5) mutants accumulated less Mn than wildtype animals, but the trend was not significant at any of the tested 
doses. Strikingly, smf-2(gk133) accumulated significantly more Mn at 35 mM (p<0.05), 100 mM (p<0.001) and 
150 mM (p<0.001) than any other strain, while smf-3(ok1035) mutants accumulated significantly less Mn than 
the other strains, both at 100 mM (p<0.001) and 150 mM (p<0.001). 
 
 
 
 
 
smf-1(eh5) mutants exhibit a Mn-dependent decrease in Fe content while smf-2(gk133) mutants are naturally 
depleted in Fe. In addition to Mn
2+
, DMT1 can transport a wide range of metallic cations including Zn
2+
, Pb
2+
, 
Cd
2+
, Ni
2+
, Co
2+
, and Fe 2+ [67]. It has been shown in rodents and cell cultures that Mn and Fe compete for 
transport via DMT1 [66,68]. In particular, high intracellular Fe levels lead to reduced Mn intake in rats [69]. To 
take into account a potential influence of Fe levels on Mn content, we analyzed Fe levels in parallel to Mn 
content. This analysis revealed that smf-2(gk133) mutants have a significantly lower Fe content than the other 
strains, which was not affected by Mn dose (Fig. 5B). Wildtype Fe levels were not significantly impacted by 0 
to 100 mM Mn exposures, but showed an increase at 150 mM. Upon transient Mn depletion, smf-1(eh5) and 
smf-3(ok1035) mutants displayed higher Fe levels, but they underwent a gradual Fe depletion with increasing 
Mn doses (Fig. 5B). smf-1(eh5) Fe content significantly dropped below WT levels when exposed to 150 mM 
Mn, suggesting a role for SMF-1 in Fe uptake at high Mn doses. 
 
SMF-1 and SMF-3 expression partially overlaps in the main epithelia while SMF-2 is restricted to minor 
epithelial tissues. 
 
To understand better the differential roles of the smf genes in C. elegans, we studied their expression pattern. 
We generated transgenic strains expressing the green fluorescent protein (GFP) under the control of smf-1, smf-
2 or smf-3 promoters (smf-1::GFP, smf-2::GFP, smf-3::GFP), as well as strains expressing GFP-tagged SMF-1, 
SMF-2 and SMF-3 (SMF-1::GFP, SMF-2::GFP, SMF3::GFP). In all cases the GFP signal was detected from 
late embryogenesis to adult stage, with generally higher expression levels in young larvae (L1 stage). None of 
the transgenic strains obtained showed any reproductive, developmental, behavioral or morphological defects, 
or intracellular GFP aggregates, thus establishing that the transgenes did not adversely affect the worms’ 
physiology and that their expression levels were likely within the physiological range. 
 
Both smf-1::GFP and SMF-1::GFP were prominently expressed in the anterior and posterior intestine and 
associated gland cells (Fig. 6A, 6B, 6C). A strong expression was observed in the anchor cell (AC) during larval 
life and in the adult proximal uterus resulting from the fusion of AC with uv1, uv2 and utse cells (Fig. 6A, 6D, 
6E). GFP signal was also consistently seen in the adult spermatheca (Fig. 6F). Fainter expression was observed 
in the major epidermis hyp7, in the pharyngeal muscles, and in a subset of anterior sensory neurons, ring 
neurons, and posterior-head neurons (Fig. 6A, 6G). SMF-3::GFP was mostly observed all along the intestine, 
with a weaker expression in the most proximal and distal regions (Fig. 6H, 6I). A weak epidermal expression in 
hyp1-6, hyp7 and hyp8-12, and in head and tail neurons was also seen (Fig. 6J, 6K, 6L, 6M). In contrast to the 
broad SMF-1::GFP and SMF-3::GFP expression patterns, SMF-2::GFP was mostly restricted to the mc1, mc2, 
mc3 epithelial cells of the pharynx and the pharyngeal-intestinal valve cells vpi1-6, displaying an anterior-
posterior expression gradient (Fig. 6N, 6O). SMF-2 was also observed in the gonad sheath cells at the adult 
stage (Fig. 6P, 6Q). 
 
SMF-1 and SMF-3 are apically localized while SMF-2 is mainly cytoplasmic. The full-length SMF-1::GFP and 
SMF-3::GFP allowed us to observe the intracellular localization of SMF-1 and SMF-3. In vertebrates, the 
DMT1 isoforms are mostly localized at the apical side in intestinal, rectal and kidney epithelial cells [66]. In 
agreement, SMF-1::GFP and SMF-3::GFP were localized at the apical plasma membrane in all epithelia in 
which they were expressed (Fig. 7A, 7B). Conversely, SMF-2::GFP was associated with intracellular 
cytoplasmic compartments and to a lesser extent to the apical membrane of the mc epithelial cells (Fig. 7C). 
 
Variation in SMFprotein levels/localization upon Mn exposure. Studies in vertebrates and yeast showed that 
DMT1 and DMT1-like isoforms are differentially regulated by metals, such as Fe and Mn [66] . In particular, 
modulation of expression and protein levels by Fe has been extensively studied [66]. In vertebrates, the DMT1 
gene encodes two to four isoforms, defining two functional types which depend upon the presence of an Iron-
Responsive Element (IRE) in their 3'UTR (+IRE isoform) or its absence (-IRE isoform) [70]. A consensus 
sequence for this IRE has been identified in several proteins involved in Fe metabolism and regulation [71]. 
Yeast studies also showed differential regulation of Smfgenes upon Mn and Fe exposure or depletion [55]. 
More specifically, in Mnreplete conditions, Smf1p and Smf2p are targeted to the vacuole for degradation, but 
they accumulate at the plasma membrane and in intracellular vesicles upon Mn depletion [56,72,73]. Unlike 
Smf1p and Smf2p, which are regulated by Mn at a post-translational level, Sm3p is regulated by Fe at a 
transcriptional level [56] . Given the impact of metal cation levels (Fe and Mn) on DMT1 isoform expression 
and localization in both vertebrate and fungus models, we addressed the possibility that C. elegans SMF 
activity may also change with environmental Mn concentration. We used C. elegans strains transgenic for the 
SMF::GFP reporters to follow DMT1-like protein expression and localization changes upon Mn exposure. We 
performed the same L1 acute treatment protocol as for our Mn toxicity and Mn content measurements, and 
collected worms at 1, 5 or 30 hours post-treatments for image analysis. SMF-1::GFP and SMF-2::GFP 
expressing worms did not show any obvious changes in either expression levels or intracellular localization. 
However, 1 hour post-treatment, SMF-3::GFP was translocated to apical vesicular compartments in the L1 
intestine (Fig. 8A, 8B); at 5 hours the intestinal GFP signal was considerably reduced; it was not solely 
restricted to the apical plasma membrane, showing also cytoplasmic expression (Fig. 8C). This phenomenon 
was reversible, since at 30 hours post-exposure, both the expression levels and the subcellular localization of 
SMF-3::GFP returned to normal (Fig. 8D). These observations are supported by quantifications of SMF-3::GFP 
fluorescence at 5 and 30 hours, showing a significant decrease of SMF-3::GFP levels at 5 hours, but not at 30 
hours post-treatment (Fig. 8E). This result suggests that SMF-3 function is regulated by Mn levels and further 
supports a major role for SMF-3 in Mn uptake. 
 
 
 
 
Figure 6. Expression pattern analysis of C. elegans smf genes. A, SMF-1:: GFP strongly localizes to the anterior and posterior intestine (solid 
white arrowheads), to the anchor cell (hollow arrowhead) and to head neurons (white arrows). Smf-1:: GFP and SMF-1:: GFP reveal expression 
of smf-1 gene in rectal gland cells (B,C, black asterisks), in the uterus (uv1, uv2, utse syncytium, D, E, solid white asterisks) as well as in the adult 
spermatheca (F) and the L1 hyp7 epidermis (G, white arrowheads). Dotted lines outline the cuticle of the worm. Hollow asterisks indicate 
position of fertilized embryos. Hollow arrowheads indicate position of the vulva. smf-3 is mainly expressed in the intestine as revealed by smf-
3::GFP (H) and SMF-3::GFP (I), in the major epidermis hyp7 (J, dotted line) and head epidermis hyp1-6 (K, dotted line), and in head (L) and 
tail neurons (M). An antero-posterior gradient of smf-2 expression is noticeable in the 9 marginal epithelial cells of the pharynx (mc1, mc2, mc3) 
and the 6 vpi cells of the pharyngeo-intestinal valve (N and O). Fainter expression is consistently observed in the proximal gonad (P, Q). Scale 
bars are 5 mm. 
doi:10.1371 /journal.pone.0007792.g006 
 
Variation in smf gene expression by RT-PCR. Given the fact that C. elegans expresses DMT1-like isoforms 
with partially overlapping expression patterns, we examined if they displayed some functional redundancy and 
if their relative expression levels were dependent on each other and on metal levels. We also wondered whether 
SMF-3::GFP down-regulation upon Mn exposure could be explained by transcriptional inhibition. To address 
these issues we conducted quantitative real-time reverse-PCR assays (QRTPCR) on wild-type, smf-1(eh5), smf-
2(gk133), and smf-3(ok1035) worms acutely exposed to 0, 1, 10, 100 mM of MnCl2. Both primers sets used to 
monitor smf gene transcriptional levels showed that smf-1 and smf-3 were up-regulated at 0.1 mM of Mn and 
down-regulated at 10 and 100 mM Mn in WT and smf mutants, but not in smf-2(gk133) (Fig. 9A, 9B, 9C). As 
expected, smf-1 expression was undetectable in smf-1(eh5), since the smf-1 primers were chosen within the 
deleted region in smf-1(eh5) (Fig. 9A). In smf-1(eh5) and smf-3(ok1035) mutants, smf-2 was also up-regulated 
at 0.1 mM of Mn and down-regulated at 10 and 100 mM Mn, while in WT, smf-2 expression was not affected 
by any of the Mn levels (Fig. 9B). 
 
Noticeably, smf-2 was strongly overexpressed in smf-1(eh5) (Fig. 9B). In smf-3(ok1035), all smf genes were 
found overexpressed compared to WT, especially smf-3 (Fig. 9C), implying that a functional SMF-3 is required 
to maintain normally low smf gene expression. Lastly, smf gene expression was not influenced by Mn exposure 
in the smf-2(gk133) genetic background (Fig. 9A, 9B, 9C). This observation supports a role for SMF-2 in smf 
gene regulation upon changes in environmental Mn status. 
 
Discussion 
We identified three new functional members of the DMT1 family in C. elegans. All three rescued the yeast 
ASMF1+2 EGTA sensitivity, and revealed important for metal homeostasis in the worm, with very little 
functional overlap. SMF-1 and SMF-3 were broadly expressed in C. elegans epithelia; they were required for 
Mn uptake and toxicity, and exhibited the classical apical localization of DMT1. Conversely, SMF-2 expression 
was essentially restricted to specialized pharyngeal cells, where it was predominantly cytoplasmic, and to 
endow partial protection against Mn-induced toxicity. SMF-1 and SMF-2 were both required for normal Fe 
intake, SMF-2 being necessary for Mndependent Fe content regulation. Mn exposure revealed influential on 
transcriptional regulation of the three smf genes, but only affected the post-translational regulation of SMF-3. 
 
 
 
Our results unravel a complex metal-regulation system involving 3 distinct DMTs coordinately regulated by 
metal levels, and bear interesting implications on the modulation of the vertebrate DMT activities carried out by 
NRAMP1 and DMT1 isoforms. 
 
SMF-3 regulates and is specifically regulated by Mn. In addition to expression and localization data, Mn 
content measurement and dose-response lethality curves in smf mutants clearly indicate that SMF-3 is a major 
Mn transporter in the worm, which is required for Mn-induced toxicity. smf-3(ok1035) is the mutant most 
resistant to acute Mn exposure (Fig. 4). SMF-3 is expressed in the epidermis and located all along the intestine, 
where most Mn absorption likely occurs (Fig. 6). SMF-3 sub-cellular localization is apical, consistent with a 
role in Mn uptake (Fig. 7). smf-3(ok1035) is the only mutant that displays a significant decrease in Mn content 
upon MnCl2 treatment (Fig. 5), implying that SMF-1 or SMF-2 cannot compensate for SMF-3 depletion.  
Moreover, SMF-3 levels and apical localization are strongly decreased 5 hours after toxic Mn exposure and are 
restored after a 24 hour recovery period (Fig. 8). Finally, QRT-PCR revealed a decrease in smf-3 mRNA levels 
upon Mn exposure at 10 and 100 mM (Fig. 9). These observations support the notion that smf-3 is down-
regulated both transcriptionally and post-translationally upon Mn exposure, which limits toxic accumulation of 
Mn in the worm. After a day of recovery allowing for the excretion of Mn accumulated upon previous exposure, 
SMF-3 levels return back to normal levels, permitting nutritional divalent cation uptake. Our experiments 
support a regulation of SMF-3 levels at the post-translational level, by relocating and degrading SMF-3. The 
translocation of SMF-3 likely to endosomal compartments in response to excessive Mn exposure can be related 
to the vacuolar targeting of Smf1p and Smf2p in Mn-replete conditions in yeast [56,73,74]. In porcine kidney 
cells, (-IRE)-DMT1 isoforms have been shown to be more rapidly and efficiently internalized upon metal 
exposure when compared to (+IRE)-DMT1 isoforms [39]. Although we did not find any typical IRE sequence 
in any of the three smf 3'UTR sequences (data not shown), we observed a drastic internalization of SMF-3 upon 
Mn treatment, but not of SMF-1 or SMF-2. Additionally, DMT1 has the highest affinity for Mn 2+ [67] and 
SMF-3 is the C. elegans orthologue that is responsible for most Mn uptake. Hence, in C. elegans, SMF-3 may 
be the functional counterpart of the vertebrate -IRE forms of DMT1. 
 
 
An atypical role for SMF-2 in Mn homeostasis. smf-2 is located downstream of smf-1 on the X chromosome. 
Due to the absence of any splice acceptor site in the smf-2 sequence and based on our GFP-reporter analysis, it 
is unlikely that smf-1 and smf-2 belong to the same operon. Indeed, both exhibited very distinct expression 
patterns (Fig. 6) and mutations in smf-1 or smf-2 have opposite effects on Mn sensitivity (Fig. 2). The high 
degree of conservation between both genes suggests that they result from a duplication that happened early in 
the Caenorhabditis lineage, since it is also found on the C. briggsae and C. remanei X chromosomes (http://dev. 
wormbase.org/db/seq/gbrowse_syn/pecan/?search_src = elegans; name = chrX%3A6716267..6721098). smf-
2(gk133) mutants exhibited hypersensitivity to Mn exposure and a higher Mn content than wild type worms 
(Fig. 2, 5), indicating that SMF-2 partially protects against Mn exposure, which may not be solely explained by 
a role in Mn uptake. The intestinal expression of SMF-1 and SMF-3 from late embryogenesis to adulthood 
strongly supports their involvement in metal uptake, while SMF-2 expression and subcellular localization in the 
pharyngeal epithelial cells is intriguing, since these cells are not known to be involved in nutrient or toxicant 
uptake (http://www. wormatlas.org/handbook/alimentary/alimentary1.htm). 
 
SMF-2 may rather be involved in the regulation of Mn toxicity, either by allowing its excretion, its 
sequestration, or the modulation of Mn uptake via the other DMT1-like isoforms, or a combination of the 
above. Because of the structural and functional similarities between SMF-3, SMF-1 and SMF-2, we favor the 
idea that pharyngeal SMF-2 takes up metallic cations, allowing for the overall regulation of Mn content. Several 
hypotheses can be formulated. First, SMF-2 could work as a sensor of environmental Mn levels, and a 
downstream signaling pathway would either impact Mn uptake via SMF-3 and SMF-1 or Mn excretion via as of 
yet uncharacterized transporters. The anterior-posterior gradient of SMF-2 expression in the pharynx would 
provide a differential mechanism to accurately estimate metal concentrations. Second, SMF-2-driven inhibition 
of Mn uptake could involve modulation of the pharyngeal pumping. The marginal cells of the pharynx, which 
express SMF-2, are electrically coupled to the pharyngeal muscles by gap junctions [75]. In mammalian cells, 
high Mn concentrations have been shown to impact cardiomyocyte contractility by inhibiting the Ca
2+
-ATPase 
[76,77]. Considering the structural and functional similarities between the C. elegans pharynx and the vertebrate 
heart [78], Mn uptake via SMF-2 in marginal cells might impact pharyngeal muscle activity. Decrease in 
pharyngeal pumping would result in reduced nutrient and Mn intake. This could also account for the slow 
growth of Mn-treated animals. Third, our Fe content analysis suggests that SMF-2 is an important Fe 
transporter. The lack of SMF-2 leads to lower Fe levels in the smf-2(gk133) worms (Fig. 5B), which would 
allow for increased Mn uptake by SMF-3 or SMF-1 (Fig. 5A). Moreover, Fe content is high at low Mn 
exposure, and drops at high Mn exposure in smf1(eh5) and smf-3(ok1035) mutants, while it is constant in smf-
2(gk133) mutants (Fig. 5B). The smf gene expression also follows this trend. It suggests that SMF-2 is required 
for Mn-dependent variations in Fe content and smf gene expression. SMF-2 is active in a different cell type as 
SMF-1 and SMF-3 (Fig. 4), and those cells are connected through gapjunctions. To reconcile these data, we 
propose that SMF-2-dependent Fe-uptake is inhibited at high Mn doses, leading to a Fe-depletion in the 
pharynx and a reversed Fe gradient across the animal. In turn this Fe imbalance, together with increased Mn 
content would lead to the down-regulation of smf genes in a SMF-2-dependent manner (Fig. 10B). 
 
Based on SMF-2::GFP subcellular localization (Fig. 7), which appears to be in puncta in the cytoplasm, but not 
in the nucleus, SMF-2 could be present in most membranous intracellular organelles of the endo-lysosomal 
pathway. Its activity could be increased by the V-ATPase-driven acidification of those compartments, similarly 
to DMT1 in endosomes and NRAMP1 in phagosomes [33], leading to metal transport to the cytosol. On the one 
hand, generation of double-transgenic C. elegans strains to conduct colocalization studies with lyzosomal 
(LAMP-1 and LAMP-2) and endosomal (RAB-5, RAB-7) markers would be beneficial in determining if the 
puncta seen in Fig. 7 correspond to endo-lyzosomal compartments. On the other hand, colocalization with an 
essential V-ATPase subunit, such as VHA-8 [89], and observation of orange acridine (pH-sensitive vital dye) 
staining in SMF-2-positive puncta and measurement of C. elegans Fe content upon variation in environmental 
pH, could be used to study the pH-dependency of SMF-2 function. 
 
SMF-1: minor in Mn physiology, major in Fe homeostasis? Though expression pattern, sub-cellular localization 
and mutant analysis might suggest an important role for SMF-1 in Mn 
2+
 uptake, Mn content measurements 
failed to show a significant difference between wild type and smf-1(eh5) mutant worms. Thus, a difference in 
Mn uptake may not account for their resistance to Mn exposure. Several hypotheses may be advanced to explain 
this apparent discrepancy. First, SMF-1 may mediate Mn toxicity subsequent to Mn uptake at the apical 
membrane of the intestine, transporting Mn from endocytic compartments to the cytosol. In absence of SMF-1, 
endocytic Mn content would remain the same, but Mn would not be transported across the membrane to reach 
the cytosol and trigger toxicity (Fig. 10). The presence of SMF-1 in intracellular vesicular organelles supports 
this idea (Fig. 7). When located at the apical plasma membrane, SMF-1 would then be largely inactive; being 
activated upon acidification of the endocytic vesicles by the vacuolar-ATPase [33,48,79]. Second, SMF-1
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contribution to Mn uptake may be minor compared to SMF-3 and Mn content measurements would not be able 
to reflect the relatively limited, yet physiologically significant variations in Mn content. This alternative 
explanation is logical within the context of the DMT family, in which different isoforms have been shown to 
transport distinct cations with variable efficiencies. Hence, the vertebrate NRAMP1 is a critical Fe transporter 
in macrophages [80,81,82], and has a poor affinity for Mn compared to DMT1 [67] . SMF-1 may thus be the 
counterpart of NRAMP1 in the worm, being predominantly required for Fe uptake. Additionally, smf-1(eh5) is 
the only mutant which showed a significant Mndependent depletion of Fe content, despite the overexpression of 
smf-2 in this context. It indicates that SMF-1 is required to take up or conserve Fe at high Mn concentrations, 
and may be responsible for Fe homeostasis (Fig. 10). Third, the QRT-PCR experiments revealed that the smf-
1(eh5) mutant exhibits a higher smf-2 expression level than wildtype, smf-2(gk133) and smf-3(ok1035) worms. 
If as mentioned previously SMF-2 is protective against Mn toxicity, the resistant phenotype of the smf-1(eh5) 
mutant may reflect the overexpression of SMF-2. In this case, SMF-1 would not necessarily be involved in Mn 
transport. Fourth, the previous hypotheses are not mutually exclusive. Lastly, SMF-1 is able to rescue EGTA 
sensitivity in yeast beyond WT level (Fig. 2). This better rescue could be due to a higher transgene copy number 
or a better stability of the SMF-1 product in the yeast, resulting in higher SMF-1 levels and a hypermorphic 
phenotype. However, it could also indicate that this transporter has a broader range of substrates than SMF-2 
and SMF-3 and may be functionally closer to a canonical DMT. 
 
New insights for the study of the eukaryotic family of DMT1-related transporters. Our analysis of the C. 
elegans DMTs reveals that they are closely related structurally and functionally to their vertebrate orthologues. 
SMF-1 and SMF-3 are apically localized in epidermal and intestinal cells, consistent with observations about 
DMT1 distribution and sub-cellular localization in vertebrates [47,85,86]. Moreover, DMT1 proteins transport 
divalent metallic cations via coupling with the proton gradient [47] in part generated by the vacuolar-ATPase 
apically localized both in vertebrates and in C. elegans epithelia [66,89,90]. Interestingly, the three C. elegans 
isoforms display distinct expression levels and contribute differentially to Mn and Fe physiology, similarly to 
the +IRE, -IRE forms of DMT1 and NRAMP1 in vertebrates. The fact that SMF-2 antagonizes SMF-3 could be 
connected to the suspected antiporter activity of NRAMP 1 relatively to the symporter activity of DMT 1. 
 
NRAMP1 was proposed to be extruding metals against the proton gradient [91]. This activity would rely on 
specific residues located before the transmembrane domains (TMD) 9 and 12, which differ between NRAMP1 
and DMT1. In particular, in mammals, NRAMP1 exhibits a basic residue K389 instead of a polar residue N403 
for DMT1, at the end of the CTS. Interestingly, our multiple-alignment reveals that all other DMT1 orthologues 
including Malvolio, SMF-3 as well as yeast Smf1p, Smf2p and Smf3p display a polar residue (N or Q) at this 
position, while SMF1 and SMF-2 show a basic residue (R or K) similarly to NRAMP1 (Fig. 1). SMF-2 also 
seemed to limit Mn accumulation. However, unlike NRAMP1, SMF-1 and SMF-2 efficiently rescue the yeast 
ASMF1+2 EGTA sensitivity. Moreover, their expression in the proximal digestive system argues against an 
antiporter activity that would result in metal extrusion. Therefore, it would be very interesting to test the ability 
of SMF-1 and SMF-2 to rescue the heavy metal ion stress in ABSD2/ARER1 yeast mutants. 
 
Ultimately the symporter or antiporter activity of DMTs may depend on the metal ions and their concentrations 
on both sides of the membrane. Environmental, cytosolic and organelle metal concentrations in yeast, oocytes, 
macrophages or distinct C. elegans cell types may vary enough for DMTs to function differently depending on 
the context. Another point is that the specific expression patterns of SMF-1, SMF-2 and SMF-3 remained the 
same through the worm’s post-embryonic life, implying that the cell-specific expression levels of smf genes are 
embryonically determined, further variations resulting from changes in metal exposure and physiology. 
 
Analysis of our results allows us to propose a working model for Mn and Fe uptake regulation in C. elegans 
(Fig. 10). We favor the notion that metal ion gradients play the key role in the regulation of expression, sub-
cellular localization and activity of DMTs in C. elegans. To further test this idea, fluorescent ferrochromes 
could be used to visualize in vivo the Fe gradient upon various Mn exposures. To yield further information on 
the metal-transport abilities of the various DMTs from worm to human, one could perform a systematical 
comparative analysis of DMT family member biochemical properties in yeast using complementation rescue of 
ABSD2/ARER1 and ASMF1+2 mutants, coupled to an in vivo study using metal-exposed transgenic C. elegans 
expressing tissue-specific chimerical DMT transgenes. Such a dual approach should help solve the paradox 
concerning the antiporter activity of NRAMP1 orthologues, and the effect of metal gradients on DMT activity. 
 
To dissect out the relative contributions of each smf gene in metal physiology in C. elegans, the generation of 
double or triple smf mutants would also be of great interest. However generation of the smf-1;smf-2 double 
mutant and the triple mutant smf-1;smf-2;smf-3 would require a new deletion mutant in which both smf-1 and 
smf2 expressions are lost, since the short genetic distance between both genes would make recombination 
events between smf-1(eh5) and smf-2(gk133) very unlikely. In addition, considering that smf-2 is strongly up-
regulated in smf-1(eh5) (Fig. 9), it is possible that the eh5 deletion, by bringing smf-1 promoting or enhancing 
sequences closer to the smf-2 gene, affects its natural expression. This potential issue should be carefully 
considered before further usage of smf-1(eh5) to generate double-mutants. Combining RNAi and single mutants 
could be another way to address the redundancy issue, with the limitation that RNAi may not be fully penetrant 
or specific enough to affect single isoforms. 
 
Relevance of our C. elegans model to study Mn toxicity and related diseases. Mn exposure has long been 
suspected to be responsible for IPD cases. The commonalities between manganism and PD suggest that both 
pathologies, at least in part, rely on shared genetic networks and molecular mechanisms. Due to the increasing 
incidence of PD, notably in most populous countries [23], there is growing interest in identifying contributing 
genetic and environmental factors. In this context, development of amenable genetic models to study gene-
environment interactions is essential. Our work corroborates the utility of C. elegans as an appropriate 
complementary whole-animal model to decipher molecular mechanisms and genetic predisposition to metal 
induced toxicity. First, we showed that C. elegans takes up Mn readily and is sensitive to Mn exposure, 
exhibiting developmental delay, excretory cell and osmoregulatory defects which can be related to kidney and 
bladder defects observed in rodents [83,84] and man [44] . The high Mn concentrations used in our study (when 
compared to cell-culture studies in which the LD50 approximates 1 mM for 24 h exposures) likely reflect three 
characteristics of the model. C. elegans is sheathed with a cuticle impermeable to ions and only few orifices 
would physically allow metal ion uptake, namely the mouth, the rectum, the pore cell of the excretory system 
and the chemosensory organs. In support of this, the Mn content measured by atomic absorption 
spetrophotometry (AAS) in wild-type worms treated at the LD50 (47 mM) corresponded to an effective dose of 
12.5 mM. Another point to consider is that the worms in the present study were acutely treated (30 min) in 
contrast to most cell culture studies that involve more protracted exposures (>24 h). It is also likely that the 
worm, naturally living in soil, where ion concentrations fluctuate greatly and rapidly, may be physiologically 
more robust than mammalian cells. Second, our functional analysis of the SMF transporters in the yeast (Fig. 2) 
together with the metal content measurements in wild type and smf mutant worms (Fig. 5A), show that the three 
C. elegans DMTs are involved in metal uptake regulation. Third, two of these transporters, SMF-1 and SMF-3 
are mostly expressed in the intestine, a portal for Mn and Fe uptake both in worms and vertebrates. SMF-1 and 
SMF-3 are also apically localized in epidermal and intestinal cells, consistent with observations about DMT1 
distribution and sub-cellular localization in vertebrates [47,85,86]. Fourth, several facts inherent to the 
regulation of DMTs by Mn or Fe and vice-versa previously described in mammalian models also hold true in C. 
elegans. For example, we showed that low Mn exposures (0.1 mM) tend to increase and high concentrations 
(100 mM) to decrease smf gene expression (Fig. 9). SMF-2 was required in this regulation process as Mn 
concentration-dependent effects are not observed in the smf-2(gk133) mutant (Fig. 5, 9). Fifth, Fe and Mn tissue 
levels are interdependent and depend on environmental concentrations. In the smf-2(gk133) mutant, low Fe 
content is associated with an increased ability to take up Mn. In smf1 (eh5), Fe content decreases with 
increasing Mn exposure (Fig. 5). Last, we found that SMF-3 N-terminal sequence contains a putative 
Mitochondrial Targeting Sequence (MTS, probability 93.66% given by MitoProt, http://ihg2.helmholtz-
muenchen.de/ihg/ mitoprot.html): MPRVHRQSRWNSVSFSGFFLQISGIKPRF. Our analysis of SMF-3::GFP 
sub-cellular localization did not reveal any epithelial mitochondrial targeting in vivo. However, it could happen 
in tissues that were not investigated in this study such as neurons, or in situations that were not covered by our 
experimental conditions. If it was confirmed, a mitochondrial targeting of DMT1 orthologues would mean that 
their activity could directly impact mitochondrial function and potentially apoptosis, in particular in 
neurodegenerative processes [87,88]. 
 
Taken together, our data suggest that Mn uptake and toxicity mechanisms involving DMTs are conserved from 
nematodes to man. Because other genetically amenable invertebrates such as D. melanogatser only express one 
DMT (Malvolio, Mvl), and given the large panel of currently available techniques on the nematode (toxicology, 
molecular biology, forward and reverse genetics, confocal and electron-microscopy, biochemistry), C. elegans 
provides a convenient in vivo platform to further investigate metal toxicity and related neurodegenerative 
disorders in which DMT1- related transporters are suspected to play an important role [87,88] . 
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